Overview

A 4 Week Study of Elidel for the Treatment of Seborrheic Dermatitis

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This is an exploratory study to determine effectiveness of Elidel for the treatment of seborrheic dermatitis
Phase:
Phase 2
Details
Lead Sponsor:
Dermatology Specialists Research
Collaborator:
Novartis
Treatments:
Pimecrolimus